Hyderabad-based Deepa Jewellers files DHRP for IPO

▴ Hyderabad-based Deepa Jewellers
Hyderabad-based Deepa Jewellers has filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) for its Initial Public Offering (IPO).
Hyderabad-based Deepa Jewellers has filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) for its Initial Public Offering (IPO).
The IPO, with a face value of Rs 2, is a fresh issue up to Rs 250 crore and an offer for sale up to 11,848,340 shares by promoters – Ashish Agarwal and Seema Agarwal.
 
The proceeds from its fresh issuance worth Rs 215 crore will be utilised for funding long-term working capital requirements towards procurement, maintenance and scaling up of inventory by the company, and general corporate purposes.
 
The issue is being made through the book-building process, in line with SEBI ICDR Regulations, with up to 50% reserved for Qualified Institutional Buyers (QIBs), not less than 15% for Non-Institutional Investors (NIIs), and at least 35% for Retail Individual Investors (RIIs).
Incorporated in 2016, the company is an organized B2B designer, processor and supplier of hallmarked gold jewellery, primarily having operations in Telangana, Karnataka, Andhra Pradesh, Tamil Nadu and Kerala. According to a CRISIL Report, the company is one of the key processors and suppliers of vaddanam and CNC machine cut bangles, distributing to jewellery retail chains and standalone stores.
It is engaged in the business of processing 22-karat gold jewellery, job-work services and trading of jewellery and related products. The company designs, processes and sells a wide range of hallmarked plain gold and precious stone studded jewellery, operating through an outsourced manufacturing model, supported by a network of 40 karigars. Its products primarily include vaddanam (waist belt), CNC machine cut bangles, gents kada, vanki(armlet), dandpatti (bajuband), gundlamala haaram (traditional neck piece), gundlamala necklace, kangan, earring, mangtika (forehead pendant), maatil (ear chain), champasaralu (ear-to-hair chain), jada (braid ornament), and rings.
 
In addition to its core jewellery processing, the company also undertakes job work assignments, wherein it receives raw material from its customers, which it processes and delivers finished ornaments to them. Furthermore, the company is also engaged in the trading of silver ornaments, 18 and 20-karat gold ornaments, precious stones and gold bullion.
 
As on November 30, 2025, the company has a product portfolio of 14 products and 76 SKUs across its product categories.
 
As of November 30, 2025, its customer network spans across 13 states and 1 union territory with a total customer base of 315 customers, comprising of 43 jewellery retail chains and 272 standalone stores. Its products span over a wide range of price points, enabling it to cater to customers across diverse segments. Its team of creative designers allows it to manage a large and wide portfolio of designs. With a diverse product portfolio and team of creative designers, the company has established a long-standing relationship with jewellery retail chains and standalone stores including, Joyalukkas India Limited, Kalyan Jewellers India Limited and Lalithaa Jewellery Mart Limited, among others.
Its revenue from operations for half year ended September 30, 2025 was Rs 812 crore and its net profit was Rs 48.6 crore. Its revenue from operations was Rs 1,397 crore during FY25 vis-à-vis Rs 921 crore during FY23. Its net profit was Rs 40.5 crore during FY25 vis-à-vis Rs 22 crore during FY23.
 
Emkay Global Financial Services and Valmiki Leela Capital are the book running lead managers, and Bigshare Services Private Limited is the registrar to the issue. The shares are proposed to be listed on the BSE and NSE. 
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026
Common Medical Terms Explained: A Plain-Language Guide for Indian Patients and Healthcare SeekersAugust 03, 2026
Why Radiology Is the Backbone of Modern Medical Diagnosis and TreatmentAugust 03, 2026
Managing Urban Stress: Science-Backed Strategies for Mental Resilience in 2026 August 01, 2026
Managing Chronic Inflammation: The Role of Anti-Inflammatory Indian SuperfoodsAugust 01, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 01, 2026
Early Markers of Glaucoma: Structural vs. Functional Ophthalmic Diagnostic ProtocolsAugust 01, 2026
Managing Complex Diabetic Foot Ulcers: Multidisciplinary Wound Care, Offloading, and RevascularizationAugust 01, 2026
The Future of Preventive Medicine: How India Is Moving From Cure to PreventionAugust 01, 2026
Why Young Indians Are Facing Heart Problems: Causes, Symptoms, and PreventionAugust 01, 2026
The Future of Preventive Screening: AI-Driven Early Cancer Detection in IndiaJuly 31, 2026
The Impact of Climate Change on Allergic Respiratory Diseases in Indian Cities July 31, 2026
Electronic Medical Records: What They Are, Why They Matter, and How India Is Embracing ThemJuly 31, 2026
Heatwave Health Risks in India: Symptoms, Treatment, and Prevention StrategiesJuly 31, 2026
Rare Chest Wall Reconstruction at SRM Global Hospital Saves Critically Injured Road Accident VictimJuly 30, 2026
52-Year-Old Male with just 10% Heart Function successfully revived at Fortis Greater Noida via High-Risk Emergency AngioplastyJuly 30, 2026
Yashoda Hospitals Hitec City Achieves Landmark Milestone of 400+ Renal Transplants in less than 4 YearsJuly 30, 2026